Biodegradable polymersomes as a basis for artificial cells: encapsulation, release and targeting.

The encapsulation of biofunctional compounds, release properties and targetability of polymersomes of amphiphilic block-copolymers based on poly(ethylene glycol) (PEG) and biodegradable polyesters or polycarbonate are described. Carboxyfluorescein (CF), as a model for hydrophilic biofunctional compounds, could be readily incorporated in the polymersomes by adding the compound to the aqueous phase during polymersome preparation. The release of encapsulated material from the polymersomes can be adjusted by changing the copolymer composition, especially the molecular weight and type of hydrophobic block of the copolymer. The presence of plasma proteins other than albumin suppressed the release of CF. CF release in PBS both at room temperature and at 60 degrees C followed first order kinetics, confirming that the CF containing polymersome system is a membrane controlled reservoir system. These biodegradable polymersomes have the potential to be targeted to specific sites in the body as shown by the specific interaction of anti-human serum albumin immobilized polymersomes with a human serum albumin coated sensor surface.

[1]  D. Lasič,et al.  Liposomes: From Physics to Applications , 1993 .

[2]  Y. Barenholz,et al.  Preparation and Characterization of Doxorubicin-Loaded Sterically Stabilized Immunoliposomes , 1996, Pharmaceutical Research.

[3]  E. Moase,et al.  Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures. , 1995, Biochimica et biophysica acta.

[4]  J. Feijen,et al.  The influence of protein adsorption on interactions of cultured human endothelial cells with polymers. , 1987, Journal of biomedical materials research.

[5]  S. Słomkowski,et al.  The direct determination of protein concentration for proteins immobilized on polystyrene microspheres. , 1991, Journal of biomaterials science. Polymer edition.

[6]  M. C. Annesini The molecular design of enzyme-loaded liposomes , 1998 .

[7]  F. Meng,et al.  Artificial cells based on biodegradable polymersomes , 2003 .

[8]  R. J. Hunter Zeta potential in colloid science : principles and applications , 1981 .

[9]  R. Müller,et al.  The role of plasma proteins in brain targeting: species dependent protein adsorption patterns on brain-specific lipid drug conjugate (LDC) nanoparticles. , 2001, International journal of pharmaceutics.

[10]  G. Storm,et al.  Immunoliposomes as Enzyme-Carriers (Immuno-Enzymosomes) for Antibody-Directed Enzyme Prodrug Therapy (ADEPT): Optimization of Prodrug Activating Capacity , 1996, Pharmaceutical Research.

[11]  D. Quintanar-Guerrero,et al.  Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers. , 1998, Drug development and industrial pharmacy.

[12]  Richard W. Baker,et al.  Controlled Release of Biologically Active Agents , 1987 .

[13]  M. Woodle,et al.  Controlling liposome blood clearance by surface-grafted polymers. , 1998, Advanced drug delivery reviews.

[14]  Ruxandra Gref,et al.  Protein encapsulation within poly(ethylene glycol)-coated nanospheres. II. Controlled release properties. , 1999, Journal of biomedical materials research.

[15]  S. Davis,et al.  Polymers in drug delivery , 1996 .

[16]  Hatem Fessi,et al.  Preparation and Characterization of Nanocapsules from Preformed Polymers by a New Process Based on Emulsification-Diffusion Technique , 1998, Pharmaceutical Research.

[17]  T M Allen,et al.  In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma. , 1998, Cancer research.

[18]  D. Lasič Sterically Stabilized Vesicles , 1994 .

[19]  U. Bakowsky,et al.  Targetability of novel immunoliposomes prepared by a new antibody conjugation technique. , 1999, International journal of pharmaceutics.

[20]  T. Allen,et al.  A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells. , 1995, Biochimica et biophysica acta.

[21]  P. Legrand,et al.  Interactions between a macrophage cell line (J774A1) and surface-modified poly (D,L-lactide) nanocapsules bearing poly(ethylene glycol). , 1999, Journal of drug targeting.

[22]  K. Maruyama,et al.  Targeting efficiency of PEG-immunoliposome-conjugated antibodies at PEG terminals , 1997 .

[23]  T. Allen,et al.  Long-circulating, polyethylene glycol-grafted immunoliposomes , 1996 .

[24]  P. Friedmann,et al.  Stabilization of large multilamellar liposomes by human serum in vitro. , 1984, Biochimica et biophysica acta.